ClinicalTrials.gg
Drug

Minocycline clinical trials

Also written Minocin and Dynacin.

studies test it
199
open now
24
in phase 3
37
first study started
1996

How each study uses Minocycline is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Minocycline studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Jun 1971 · MINOCIN · NDA 050315 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Minocycline
140
Minocycline Hydrochloride
16
Minocin PAC
13
Myrac
12
Minocycline hydrochloride capsule
5

Brand

Minocin
37
Dynacin
15
Solodyn
15
Arestin
4

Development codes

BPX-01
1

In one entry with another drug

Given together, or one or the other

Triple Antibiotic Paste
6
Minocycline,Metronidazole
3

Studies by the year they started

196 studies that test it; most in 2013 (15); 1 more planned to start later

Studies that test Minocycline, by start year
YearStudies
19961
19971
20011
20022
20035
20044
20067
20077
20085
20095
201013
201112
201211
201315
201410
201511
20168
201711
20185
20198
20207
20211
20229
202313
20248
20255
202611

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
42
Phase 2
77
Phase 3
37
Phase 4
42
No phase
25

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 28 · Other 171

M.D. Anderson Cancer Center (11) · National Eye Institute (NEI) (5) · OraPharma (5) · Xijing Hospital (4) · University of Florida (4) · Pakistan Institute of Living and Learning (4) · Ranbaxy Laboratories Limited (4) · University of North Carolina, Chapel Hill (3)

Often tested with

Tested in the same studies.

Metronidazole (10) · Ciprofloxacin (6) · Modafinil (4) · Celecoxib (4) · Trimethoprim, Sulfamethoxazole Drug Combination (2) · Mupirocin (2) · Hydroxychloroquine (2) · Lovastatin (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4, 1 in phase 3

Studies that test Minocycline, phase 3 first.

Studies

Open first, then newest update. How each study uses Minocycline is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 199

See all 199 studies that test Minocycline →

Given beside what is tested · 9 — Minocycline is usual care or a partner of the new treatment
As the comparator · 7 — what is tested is compared with Minocycline

Codes

What other systems call Minocycline · ClinicalTrials.gg INT007840

  • MeSH (NLM) D008911MinocyclineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) FYY3R43WGOMINOCYCLINEConfirmed FDA, NLM, Wikidata
  • RxNorm 6980Confirmed FDA, Wikidata
  • Wikidata Q415336minocyclineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61849MinocyclineOne source FDA
  • DrugBank DB01017One source Wikidata

Also registered as minocycline hydrochloride (UNII 0020414E5U · RxNorm 6979).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.